Pig ficolins and a number of other proteins contain sequences that are homologous to the C-terminal halves of fibrinogen β-and γ-chains. To clone the cDNA for human ficolin, two degenerate oligonucleotide primers were synthesized, based on two stretches of protein sequence that were highly conserved among those proteins, and used for PCR with cDNA from a human uterus λgt11 library as a template. A PCR product with a predicted size of 300 bp was obtained and this was used to screen a uterus cDNA library. Of the positive clones isolated, two (U1 and U2), containing inserts of 1.7 and 1.1 kb respectively, were found to encode human ficolin. The cDNA-derived amino acid sequence of human ficolin has approx. 75% identity with, and a similar domain organization to, the two pig ficolin sequences, which are characterized by the presence of a leader peptide, a short N-terminal segment followed by a collagen-like region and then by a C-terminal fibrinogen-like domain. The 1.1 kb insert of clone U2 was used in Northern-blot analysis, and a very strong signal for a 1.4 kb mRNA species was detected in mRNA from human peripheral blood leucocytes. This showed that, despite the initial characterization of pig ficolin as a putative receptor on uterine cells for transforming growth factor β1, blood leucocytes are probably the major site of human ficolin synthesis. Much weaker signals of the same size were also detected in spleen, lung and thymus and may be due to the presence of tissue macrophages or trapped blood in these tissues. An mRNA species of approx. 1.3 kb in human liver also weakly hybridized to the U2 probe, indicating the presence of a sequence that was distinct from, but related to, ficolin. The gene for human ficolin has been mapped to chromosome 9.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
January 1996
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Research Article|
January 15 1996
Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9 Available to Purchase
Jinhua LU;
Jinhua LU
‡
*Department of Biochemistry, Faculty of Medicine, National University of Singapore, 10 Kent Ridge Crescent, Singapore 0511m, U.K.
‡To whom correspondence should be addressed.
Search for other works by this author on:
Puei Nam TAY;
Puei Nam TAY
*Department of Biochemistry, Faculty of Medicine, National University of Singapore, 10 Kent Ridge Crescent, Singapore 0511m, U.K.
Search for other works by this author on:
Oi Lian KON;
Oi Lian KON
*Department of Biochemistry, Faculty of Medicine, National University of Singapore, 10 Kent Ridge Crescent, Singapore 0511m, U.K.
Search for other works by this author on:
Kenneth B. M. REID
Kenneth B. M. REID
†MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
May 10 1995
Revision Received:
August 23 1995
Accepted:
September 13 1995
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London © 1996
1996
Biochem J (1996) 313 (2): 473–478.
Article history
Received:
May 10 1995
Revision Received:
August 23 1995
Accepted:
September 13 1995
Citation
Jinhua LU, Puei Nam TAY, Oi Lian KON, Kenneth B. M. REID; Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9. Biochem J 15 January 1996; 313 (2): 473–478. doi: https://doi.org/10.1042/bj3130473
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |